Results 11 to 20 of about 81,608 (302)

Can BAP1 expression loss in mesothelial cells be an indicator of malignancy? [PDF]

Journal of Pathology and Translational Medicine, 2020
Background Malignant mesothelioma is a highly aggressive tumor that can be confused with a benign mesothelial lesion, especially cytomorphologic lesions. BRCA1-associated protein 1 (BAP1) acts as a tumor suppressor.
Hanife Gulnihal Ozdemir, Sermin Coban Kokten, Nagehan Ozdemir Barisik   +2 more
doaj   +1 more source

Diagnostic and Therapeutic Challenges of Malignant Pleural Mesothelioma

Diagnostics, 2022
Malignant pleural mesothelioma is a rare cancer characterized by a very poor prognosis. Exposure to asbestos is the leading cause of malignant pleural mesothelioma.
Jacopo Moro, Simona Sobrero, Carlotta Francesca Cartia, Simona Ceraolo, Roberta Rapanà, Federico Vaisitti, Stefano Ganio, Federica Mellone, Stefano Rudella, Federico Scopis, Danilo La Paglia, Carola Crystel Cacciatore, Enrico Ruffini, Francesco Leo   +13 more
doaj   +1 more source

Malignant pleural mesothelioma [PDF]

European Respiratory Journal, 1998
The incidence of malignant pleural mesothelioma (MPM) has risen for some decades and is expected to peak between 2010 and 2020. Up to now, no single treatment has been proven to be effective and death usually occurs within about 12-17 months after diagnosis. Perhaps because of this poor prognosis, early screening has incited little interest.
C, Boutin, M, Schlesser, C, Frenay, P, Astoul   +3 more
openaire   +4 more sources

Highlighting the immunohistochemical differences of malignant mesothelioma subtypes via case presentations

Thoracic Cancer, 2023
Malignant mesothelioma (MM) is a rare tumor of mesothelial cells, with an increasing incidence both in developed and developing countries. MM has three major histological subtypes, in order of frequency, according to the World Health Organization (WHO ...
Anita Sejben, Tamás Pancsa, László Tiszlavicz, József Furák, Dóra Paróczai, Tamás Zombori   +5 more
doaj   +1 more source

Can malignant and inflammatory pleural effusions in dogs be distinguished using computed tomography [PDF]

, 2017
Computed tomography (CT) is the primary imaging modality used to investigate human patients with suspected malignant or inflammatory pleural effusion, but there is a lack of information about the clinical use of this test in dogs.
Aquino, Bedford, Benamore, Caivano, Ceribasi, Charney, D'Angelo, Dempsey, Dubielzig, Echandi, Fossum, Gumber, Hirsch, Hung, Kawashima, Lara-Garcia, Metintas, Morrison, Mott, Müller, Nakamura, Prather, Przeździecki, Rebar, Reetz, Sahin, Smith, Swinbourne, Thrall, Traill, Tyler, Vansteenkiste, Vogtli, Waite, Wang, Yamamoto   +35 more
core   +1 more source

Mesothelioma and thymic tumors: Treatment challenges in (outside) a network setting [PDF]

, 2019
The management of patients with mesothelioma and thymic malignancy requires continuous multidisciplinary expertise at any step of the disease. A dramatic improvement in our knowledge has occurred in the last few years, through the development of ...
Girard, N, Grassino, M, Imbimbo, M, Maury, J, Vitale, F   +4 more
core   +1 more source

Bilateral diffuse pulmonary infiltrates secondary to malignant peritoneal mesothelioma – A rare clinical presentation

Respiratory Medicine Case Reports, 2019
Diffuse pulmonary metastasis secondary to primary peritoneal malignant mesothelioma is rarely reported in the literature. In this report we describe a 59-year-old Caucasian women with no known previous asbestos exposure presenting with bilateral diffuse ...
Madeleine Haygarth, Kyi Kyi Zaw, Victoria Yachmenikova, Adrian M.J. Pokorny, Kin Keung Kwong, Subash S. Heraganahally   +5 more
doaj   +1 more source

Survival prediction in mesothelioma using a scalable lasso regression model: instructions for use and initial performance using clinical predictors [PDF]

, 2018
Introduction: Accurate prognostication is difficult in malignant pleural mesothelioma (MPM). We developed a set of robust computational models to quantify the prognostic value of routinely available clinical data, which form the basis of published MPM ...
Blyth, Kevin G., Bylesjo, Max, Halligan, Daniel L., Kidd, Andrew C., McGettrick, Michael, Tsim, Selina   +5 more
core   +1 more source

Multiple malignant epithelioid mesotheliomas of the liver and greater omentum: a case report and review of the literature

Surgical Case Reports, 2017
Background Malignant mesothelioma commonly arises from the pleura, but can also arise from the peritoneum, pericardium, and tunica vaginalis testis.
Koji Minami, Hiroshi Okumura, Kiyokazu Hiwatashi, Sumika Matsukita, Tetsuro Setoyama, Kota Minamimagari, Yusuke Tsuruta, Ichiro Kanetsuki, Yoshito Ogura, Shigeho Maenohara, Shoji Natsugoe   +10 more
doaj   +1 more source

Pathologic diagnosis of malignant mesothelioma: chronological prospect and advent of recommendations and guidelines [PDF]

, 2015
Malignant mesothelioma is rare and difficult to diagnose. Its identification depends upon pathological investigation (cyto-histological assessment and immunohistochemistry) supported by clinical and radiological evidence.
Ascoli, Valeria
core   +2 more sources